Evropi Theodoratou
Overview
Explore the profile of Evropi Theodoratou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
187
Citations
12485
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao J, Xu L, Sun J, Song M, Wang L, Yuan S, et al.
BMJ Oncol
. 2025 Jan;
2(1):e000049.
PMID: 39886513
Objective: This study aimed to explore the global burden of early-onset cancer based on the Global Burden of Disease (GBD) 2019 study for 29 cancers worldwid. Methods And Analysis: Incidence,...
2.
Xu W, Mesa-Eguiagaray I, Morris D, Wang C, Gray C, Sjostrom S, et al.
Nat Commun
. 2025 Jan;
16(1):99.
PMID: 39747859
Bone marrow adipose tissue is a distinct adipose subtype comprising more than 10% of fat mass in healthy humans. However, the functions and pathophysiological correlates of this tissue are unclear,...
3.
Chen J, Zhang H, Fu T, Zhao J, Nowak J, Kalla R, et al.
EBioMedicine
. 2024 Nov;
110:105443.
PMID: 39536393
Background: This study aims to confirm the associations of air pollution with ulcerative colitis (UC) and Crohn's disease (CD); to explore interactions with genetics and lifestyle; and to characterize potential...
4.
Gerrard A, Coxon J, Maeda Y, Theodoratou E, Dunlop M, Din F
BJS Open
. 2024 Oct;
8(5).
PMID: 39404039
Background: This study aimed to describe the faecal immunochemical test non-return rate of those referred with high-risk symptoms of colorectal cancer from primary care, and the clinical outcomes of the...
5.
Gerrard A, Garau R, Xu W, Maeda Y, Dunlop M, Theodoratou E, et al.
Cancers (Basel)
. 2024 Sep;
16(18).
PMID: 39335170
Background: Faecal immunochemical testing (FIT) is widely used in bowel screening programmes and assessing symptomatic patients for suspected colorectal cancer (CRC). The evidence for single test performance of FIT in...
6.
Wang L, Mesa-Eguiagaray I, Campbell H, Wilson J, Vitart V, Li X, et al.
Eur J Epidemiol
. 2024 Jul;
39(8):869-880.
PMID: 38992218
Uric acid has been linked to various disease outcomes. However, it remains unclear whether uric acid-lowering therapy could be repurposed as a treatment for conditions other than gout. We first...
7.
Dai S, Wellens J, Yang N, Li D, Wang J, Wang L, et al.
Clin Nutr
. 2024 Apr;
43(6):1386-1394.
PMID: 38688162
Background & Aims: Ultra-processed food (UPF) intake has increased sharply over the last few decades and has been consistently asserted to be implicated in the development of non-communicable diseases. We...
8.
Bian Z, Wang L, Fan R, Sun J, Yu L, Xu M, et al.
BMJ Evid Based Med
. 2024 Apr;
29(4):255-263.
PMID: 38684374
Objective: To investigate the associations across genetic and lifestyle factors with lifespan. Design: A longitudinal cohort study. Setting: UK Biobank. Participants: 353 742 adults of European ancestry, who were recruited...
9.
Chen Z, Guo X, Tao R, Huyghe J, Law P, Fernandez-Rozadilla C, et al.
Nat Commun
. 2024 Apr;
15(1):3557.
PMID: 38670944
Genome-wide association studies (GWAS) have identified more than 200 common genetic variants independently associated with colorectal cancer (CRC) risk, but the causal variants and target genes are mostly unknown. We...
10.
Sun J, Zhao J, Zhou S, Li X, Li T, Wang L, et al.
J Natl Cancer Inst
. 2024 Apr;
116(8):1303-1312.
PMID: 38648753
Background: We aimed to identify plasma and urinary metabolites related to colorectal cancer (CRC) risk and elucidate their mediator role in the associations between modifiable risk factors and CRC. Methods:...